Indivi develops functional biomarkers that measure key disability concepts of importance for drug development trials in neuroscience
Indivi has raised $18.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Indivi's investors include Ava Investors, Lichtsteiner Foundation, Zühlke Ventures AG.
Indivi is headquartered in Basel, Switzerland.
Indivi develops functional biomarkers that measure key disability concepts of importance for drug development trials in neuroscience
Indivi is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Indivi — Funding & Investors." VCBacked, November 12, 2025, https://www.vcbacked.co/company/indivi. Accessed September 30, 2026.
VCBacked. (2025). Indivi — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/indivi
{{cite web |title=Indivi — Funding & Investors |url=https://www.vcbacked.co/company/indivi |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated